Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality

BACKGROUND: The US Food and Drug Administration authorized COVID-19 convalescent plasma (CCP) therapy for hospitalized COVID-19 patients via the Expanded Access Program (EAP) and the Emergency Use Authorization (EUA), leading to use in about 500,000 patients during the first year of the pandemic for...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:eLife
Hlavní autoři: Casadevall, Arturo, Dragotakes, Quigly, Johnson, Patrick W, Senefeld, Jonathon W, Klassen, Stephen A, Wright, R Scott, Joyner, Michael J, Paneth, Nigel, Carter, Rickey E
Médium: Artigo
Jazyk:Inglês
Vydáno: eLife Sciences Publications, Ltd 2021
Témata:
Epidemiology and Global Health
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8205484/
https://ncbi.nlm.nih.gov/pubmed/34085928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7554/eLife.69866
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky